Cargando…
Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality.
INTRODUCTION: According to the ICD-10 classification system, manic episodes in bipolar affective disorder (BAD) are typically characterised by sudden onset of symptoms and a duration between two weeks and five months. Mood stabilizers and 2(nd) generation antipsychotics are recommended as first-line...
Autores principales: | Papadimitriou, N., Antoniadis, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418038/ http://dx.doi.org/10.1192/j.eurpsy.2023.2151 |
Ejemplares similares
-
Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics
por: McClay, Joseph L., et al.
Publicado: (2009) -
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004) -
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
por: Lally, John, et al.
Publicado: (2016) -
Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
por: Koromina, Maria, et al.
Publicado: (2020) -
Pharmacogenomics
Publicado: (2008)